5 completed. 5 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 2 | Completed 2 |
Follow Bacterial Conjunctivitis: new trials by email Literature Review of Bacterial Conjunctivitis trials Research Report on Bacterial Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) PRO-157, Vigamox, Zymar® - Bacterial Conjunctivitis | Phase 2 | Completed | Laboratorios Sophia S.A de C.V. | 150 | 2015-03-01 | 2019-05-22 |
| Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis Auriclosene Solution 0.3%, Auriclosene Vehicle - Bacterial Conjunctivitis | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 217 | 2013-06-01 | 2015-05-28 |
| Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis Besifloxacin, Vehicle (Placebo) - Bacterial Conjunctivitis | Phase 2 / Phase 3 | Completed | Bausch & Lomb Incorporated | 474 | 2009-10-01 | 2012-03-29 |
| Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis ISV-403, Vehicle - Bacterial Conjunctivitis | Phase 2 | Completed | Bausch & Lomb Incorporated | 270 | 2004-12-01 | 2015-03-24 |
| Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis 0.5% levofloxacin eye drops - Bacterial Conjunctivitis | Phase 2 / Phase 3 | Completed | Laser Microsurgery Centre, Poland | 119 | 2004-09-01 | 2007-11-29 |
Conjunctivitis, Bacterial (5) · Conjunctivitis (1)
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Conjunctival Diseases (5) · Eye Diseases (5) · Eye Infections (5) · Eye Infections, Bacterial (5) · Infections (5) · Conjunctivitis (4)
besifloxacin (2) · Gatifloxacin (1) · Moxifloxacin (1) · NVC-422 (1) · Ophthalmic Solutions (1) · pazufloxacin (1)
Bausch & Lomb Incorporated (2) · Laboratorios Sophia S.A de C.V. (1) · Laser Microsurgery Centre, Poland (1) · NovaBay Pharmaceuticals, Inc. (1)
United States (2) · Mexico (1) · Poland (1)
David W. Stroman, Ph.D. (1) · Jerzy Szaflik, MD,Ph.D. (1) · Leopoldo Baiza, MD (1) · Michael R Paterno, OD (1) · Timothy Comstock, OD (1)
PMID 19393842, PMID 20629472, PMID 21397770, PMID 22420526, PMID 22644963, PMID 29602567, PMID 32841261